Degradation of unassembled soluble Ig subunits by cytosolic proteasomes: evidence that retrotranslocation and degradation are coupled events
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Many aberrant or unassembled proteins synthesized in the endoplasmic reticulum (ER) are degraded by cytosolic proteasomes. To investigate how soluble glycoproteins destined for degradation are retrotranslocated across the ER membrane, we analyzed the fate of two IgM subunits, μ and J, retained in the ER by myeloma cells that do not synthesize light chains. Degradation of μ and J is prevented by proteasome inhibitors, suggesting that both chains are retrotranslocated to be disposed of by proteasomes. Indeed, when proteasomes are inhibited, some deglycosylated J chains that no longer contain intrachain disulfide bonds accumulate in the cytosol. However, abundant glycosylated J chains are still present in the ER at time points in which degradation would have been almost complete in the absence of proteasome inhibitors, suggesting that retrotranslocation and degradation are coupled events. This was confirmed by protease protection and cell fractionation assays, which revealed that virtually all μ chains are retained in the ER lumen in a glycosylated state when proteasomes are inhibited. Association with calnexin correlated with the failure of μ chains to dislocate to the cytosol. Taken together, these results suggest that active proteasomes are required for the extraction of Ig subunits from the ER, though the requirements for retrotranslocation may differ among individual substrates.—Mancini, R., Fagioli, C., Fra, A. M,. Maggioni, C., Sitia, R. Degradation of unassembled soluble Ig subunits by cytosolic proteasomes: evidence that retrotranslocation and degradation are coupled events. FASEB J. 14, 769–778 (2000)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A proteolytic system that compensates for loss of proteasome function
Glas, R., Bogyo, M., McMaster, J. S., Gaczynska, M., & Ploegh, H. L. (1998) · Nature · doi:10.1038/33443 · Cited by 270
Cited by
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Obeng, E. A., Carlson, L. M., Gutman, D. M., Harrington, W. J., Lee, K. P., & Boise, L. H. (2006) · Blood · doi:10.1182/blood-2005-08-3531 · Cited by 1,143
In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases
Hebert, D. N., & Molinari, M. (2007) · Physiological Reviews · doi:10.1152/physrev.00050.2006 · Cited by 671
Protein quality control in the early secretory pathway
Anelli, T., & Sitia, R. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601974 · Cited by 623
“Proteasome inhibitors generally impair disloca- tion (Chillaron and Haas, 2000; Mancini et al, 2000), implying that the above steps (dislocation, ubiquitination, proteolysis) are tightly coupled.”
BackgroundSelf-citationRabinovich, E., Kerem, A., Fröhlich, K.-U., Diamant, N., & Bar-Nun, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.626-634.2002 · Cited by 546
Extensive Immunoglobulin Production Sensitizes Myeloma Cells for Proteasome Inhibition
Meister, S., Schubert, U., Neubert, K., Herrmann, K., Burger, R., Gramatzki, M., Hahn, S., Schreiber, S., Wilhelm, S., Herrmann, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2258 · Cited by 410
The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation
Saliba, R. S., Munro, P. M. G., Luthert, P. J., & Cheetham, M. E. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.14.2907 · Cited by 344
N-glycan processing in ER quality control
Ruddock, L. W., & Molinari, M. (2006) · Journal of Cell Science · doi:10.1242/jcs.03225 · Cited by 300
Tsai, Y. C., Fishman, P. S., Thakor, N. V., & Oyler, G. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212235200 · Cited by 283
ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family
Anelli, T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.835 · Cited by 273
Htm1p, a mannosidase‐like protein, is involved in glycoprotein degradation in yeast
Jakob, C. A., Bodmer, D., Spirig, U., Bättig, P., Marcil, A., Dignard, D., Bergeron, J. J. M., Thomas, D. Y., & Aebi, M. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve089 · Cited by 252
“There have been several reports that indicate a distinct function of N-glycan trimming by mannosidase I in glycoprotein degradation (Liu et al., 1997, 1999; Yang et al., 1998; Cabral et al., 2000; Mancini et al., 2000; Wang and Androlewicz, 2000; Wang and White, 2000).”
BackgroundQuality Control of Orphaned Proteins
Juszkiewicz, S., & Hegde, R. S. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.001 · Cited by 165
Spiro, R. G. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-004-4037-8 · Cited by 149
Hsp90 Inhibition Decreases Mitochondrial Protein Turnover
Margineantu, D. H., Emerson, C. B., Diaz, D., & Hockenbery, D. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001066 · Cited by 147
Inactivation of VCP/ter94 Suppresses Retinal Pathology Caused by Misfolded Rhodopsin in Drosophila
Griciuc, A., Aron, L., Roux, M. J., Klein, R., Giangrande, A., & Ueffing, M. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001075 · Cited by 78
“Our pharmacological treatment with the proteasome inhibitor MG132 also led to a dramatic suppression of retinal degeneration in the Rh1 retina and the proteasome was shown to be tightly coupled to substrate retrotranslocation during ERAD [15,62,63].”
Free oligosaccharide regulation during mammalian protein N-glycosylation
Chantret, I., & Moore, S. E. H. (2007) · Glycobiology · doi:10.1093/glycob/cwn003 · Cited by 75
Zhang, L., Fok, J. J. L., Mirabella, F., Aronson, L. I., Fryer, R. A., Workman, P., Morgan, G. J., & Davies, F. E. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.023 · Cited by 32
Metadata
- Authors
- Mancini, R., Fagioli, C., Fra, A. M., Maggioni, C., & Sitia, R.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-04
- Volume
- 14
- Issue
- 5
- Pages
- 769-778
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1915442041
- Cited by
- 96
- References
- 1
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.